Graham Capital Management, L.P. Axonics, Inc. Transaction History

Graham Capital Management, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$56.67 - $69.36 $580,414 - $710,385	10,242 New	10,242 $706,000
Q2 2023 Aug 14, 2023	SELL	$47.99 - $60.21 $592,340 - $743,172	-12,343 Reduced 19.02%	52,561 $2.65 Million
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $133,656 - $171,110	2,541 Added 4.07%	64,904 $3.54 Million
Q4 2022 Feb 14, 2023	BUY	$59.56 - $76.6 $782,856 - $1.01 Million	13,144 Added 26.71%	62,363 $3.9 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $629,735 - $848,773	10,865 Added 28.33%	49,219 $3.47 Million
Q2 2022 Aug 15, 2022	SELL	$39.5 - $64.42 $32,785 - $53,468	-830 Reduced 2.12%	38,354 $2.17 Million
Q1 2022 May 16, 2022	BUY	$43.74 - $62.76 $1.71 Million - $2.46 Million	39,184 New	39,184 $2.45 Million

221

42M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.